Latest Form 4 insider transactions

Todd M Duchene, See remarks of Core Scientific, Inc./tx, sold 10,000 shares of common stock on October 12, 2026 for $15.12 per share.

Bhaskar Anand, Chief Accounting Officer of Summit Therapeutics Inc., received 100,000 shares of common stock on October 8, 2026.

John T Hall, Chief Executive Officer and a Director of Intapp, Inc., sold 3,000 shares of common stock on October 12, 2026 for $40.00 per share.

Robert Paul Myers, Chief Medical Officer of Mirum Pharmaceuticals, Inc., reported multiple transactions in common stock on October 9, 2026.

William Brundage, Chief Financial Officer and a Director of Ferguson Enterprises Inc. /DE/, sold 5,986 shares of common stock on October 12, 2026 for $218.74 per share.

Andrew C. Wiechmann, Chief Financial Officer of MSCI Inc., sold 450 shares of common stock on October 12, 2026 for $570.00 per share.

Tobin W Juvenal, Chief Commercial Officer of Castle Biosciences Inc, sold 3,288 shares of common stock on October 12, 2026 for $33.64 per share.

Jr Stephen M Ward, a Director of Carpenter Technology Corp, reported multiple transactions in common stock on October 9, 2026.

Attias Gali Yahav, Chief Corporate Resources of Nano-X Imaging Ltd., received 28,283 shares of common stock on October 14, 2026.

Sharon Saban, General Manager AI Division of Nano-X Imaging Ltd., received 28,283 shares of common stock on October 14, 2026.

Guy Nathansohn, Chief Financial Officer of Nano-X Imaging Ltd., received 50,000 shares of common stock on October 14, 2026.

Stephen Simon Schifrin, a Director of Yatra Online, Inc., received 10,269 shares of common stock on October 14, 2026.

Roshan Mendis, a Director of Yatra Online, Inc., received 10,269 shares of common stock on October 14, 2026.

Michael A Kaufman, a Director of Yatra Online, Inc., received 7,602 shares of common stock on October 14, 2026.

Feler Marina Gofman, Chief Legal Officer of Nano-X Imaging Ltd., received 28,283 shares of common stock on October 13, 2026.

Den Born Simon Van, President of Marex Group plc, sold 15,272 shares of common stock on October 12, 2026.

Paolo Tonucci, See Remarks of Marex Group plc, sold 16,666 shares of common stock on October 12, 2026.

Stefan J. Murry, Chief Financial Officer of Applied Optoelectronics, Inc., sold 4,000 shares of common stock on October 12, 2026 for $102.87 per share.

Jeremy Skule, EVP, CSO of Nasdaq, Inc., sold 1,125 shares of common stock on October 12, 2026 for $94.13 per share.

Philippe Menu, Chief Medical Officer of SOPHiA GENETICS SA, sold 5,000 shares of common stock on October 12, 2026 for $7.26 per share.

Zhenyu Xu, Chief Scientific Officer of SOPHiA GENETICS SA, sold 4,000 shares of common stock on October 13, 2026 for $7.18 per share.

Erik Weaver, EVP & Chief Financial Officer of Life Time Group Holdings, Inc., sold 5,787 shares of common stock on October 12, 2026 for $39.77 per share.

Ray Michael Bibisi, President and COO of R F Industries Ltd, reported multiple transactions in common stock on October 11, 2026.

Lauren C Templeton, a Director of Canadian Solar Inc., received 2,716 shares of common stock on October 12, 2026.

Peter Yin, Chief Financial Officer of R F Industries Ltd, reported multiple transactions in common stock on October 11, 2026.

Robert D Dawson, CEO and a Director of R F Industries Ltd, reported multiple transactions in common stock on October 11, 2026.

Jurgi Camblong, Executive Chairman and a Director of SOPHiA GENETICS SA, sold 8,500 shares of common stock on October 12, 2026 for $7.26 per share.

Harry E Ruda, a Director of Canadian Solar Inc., received 2,716 shares of common stock on October 12, 2026.

Robert O'Hare, Chief Financial Officer of Affirm Holdings, Inc., sold 65,591 shares of common stock on October 9, 2026 for $80.02 per share.

Rajesh Subramaniam, a Director of PROCTER & GAMBLE Co, received 1,438 shares of common stock on October 13, 2026.